Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good luck.
At the risk of assuming that I fit the definition:
Yes.
I would be more inspired if the executive team showed similar commitment - they may not have a choice about the R/S if trading volume continues on pace, without a corresponding price appreciation.
Partnership would be welcome.
On the fence - they sold ATM during last data release, and don’t have a strategy to support common shares at this level. They need funding, and have no milestones for the next 12 months.
7 more days below $1.00 earns them delisting notice, and I can’t tell if new management has the balls not to R/S.
Less than a month away.
Nymox Announces Date for Fexapotide Filing
NEWS RELEASE
HASBROUCK HEIGHTS, NJ (May 6, 2021) Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it will be filing for marketing approval of Fexapotide Triflutate for BPH before the end of the summer, on or before 15 September 2021.
CEO Dr Paul Averback said, "The Company will file on or before September 15. We hope but cannot be certain that the date may be before September. Company management will communicate updates where appropriate."
https://nymox.com/files/download/45b2b195922068b
Thanks for the “boots on the ground” reporting.
At the risk of going over covered ground - I thought that the Calorie Counter was supposed to be released first (pre-order) for $99.
https://www.businesswire.com/news/home/20180815005229/en/Know-Labs-Announces-UBAND™-Calorie-Counter-Wristband
Then - CGM became the focus.
https://www.knowlabs.co/investors
Then - Particle Light Bulb became the focus.
In light of the lack of company feedback about Uband testing for CGM, there is little else to cling to. Raising money without providing solid milestones relieves management from delivering on projected accomplishments while getting more money for salaries and “ corporate purposes”.
If Ron Erickson was the real deal, he would provide details and due by dates for UBAND coming to market.
So - the lack of an update from
Appreciate the reporting from the frontline.
Uh - no. The other rumor:
That would be news indeed - I sure haven’t “heard” that. Have you? Anybody in particular starting this rumor?
Some context for recent presentations
LD Micro earlier today
https://ve.mysequire.com/recording?session_id=e73df1f0-8e33-4f2a-9cc5-fe2f43b11754
Know Labs Provides Update on Company Business, Impact of Covid-19
https://medium.com/know-labs/know-labs-provides-update-on-company-business-impact-of-covid-19-8d9179d1f9f3
HAHAHAHA!!!
(That’s me, laughing while I think about the connection)
Arch Therapeutics' AC5 Heals Recalcitrant Diabetic Foot Ulcer
https://seekingalpha.com/article/4375810-arch-therapeutics-ac5-heals-recalcitrant-diabetic-foot-ulcer
Arch Therapeutics Reports First Pressure Ulcer Case Results https://seekingalpha.com/article/4373876-arch-therapeutics-reports-first-pressure-ulcer-case-results
Lofty price target, but good to see that at least some feedback from end users is trickling in
So it’s possible that this application is still being processed.....?
Weird - is this one still pending?
https://www.dec.ny.gov/cfmx/extapps/envapps/index.cfm?view=detail&applid=1161861
It was right below the one you posted:
Arch Therapeutics Receives Recommendation That CE Mark Be Granted $ARTH https://seekingalpha.com/article/4308381
So you’re saying there’s a chance.......
The timeliness of his filings is less interesting than why he is filing at all, or why they continue to issue themselves shares at any price in a dormant public company......
“One man’s trash is another man’s treasure”
N’est ce pas?
And yet......it is.
Go figure - efficiencies, schmeffiencies. Maybe the market just can’t be bothered to bend tiny little PTOI into rationale-based submission.....
My calculator must be wrong - almost $3,200 worth of shares have been traded.
The short cabal is toast.
Hey Steelyeye -
Good to see you posting again. Hope your summer is going well.
Fun to watch, for sure - can’t understand why it’s not triple 000s right now, based on expert projections.
Imagine what might happen if they sell a processor or two......
What do you think of the other possibilities' chances?